@jc403.bsky.social
📤 9
📥 108
📝 0
reposted by
Gilbert Gerber
about 1 month ago
So many settings low dose IL-2 could be beneficial. This is the type of collaborative studies public money should be used for.
0
2
1
reposted by
Daniel Drucker
about 1 month ago
After 6 weeks of Rx patients with ACSs, low-dose IL-2 safely increases Tregcell levels and reduces arterial inflammation.
www.nature.com/articles/s41...
loading . . .
Anti-inflammatory therapy with low-dose IL-2 in acute coronary syndromes: a randomized phase 2 trial - Nature Medicine
In a randomized phase 2 trial in patients with acute coronary syndrome and high levels of the inflammation biomarker C-reactive protein, treatment with low-dose interleukin-2 increased the numbers of ...
https://www.nature.com/articles/s41591-025-04090-y
1
5
3
you reached the end!!
feeds!
log in
